Case study - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

Case study

Description:

A twenty year old lady undergoes a laparotomy for a ruptured ectopic pregnancy ... Laudanosine. Metabolite of Cisatracurium. No neuromuscular blocking activity ... – PowerPoint PPT presentation

Number of Views:68
Avg rating:3.0/5.0
Slides: 20
Provided by: cmuh5
Category:

less

Transcript and Presenter's Notes

Title: Case study


1
  • Case study
  • -Muscle Relaxant

Intern ???
2
Case Presentation
  • A twenty year old lady undergoes a laparotomy
    for a ruptured ectopic pregnancy under general
    anesthesia
  • Mass 60kg
  • No abnormalities found in the preoperative
    history and examination
  • It is, however , her first anesthetic

3
  • She receives
  • Propofol 120 mg
  • Suxamethonium (Succinylcholine) 60 mg
  • Cisatracurium 8 mg
  • Fentanyl 100 µg
  • O2/air/sevoflurane
  • Atropine 0.4mg
  • Neostigmine 2.5mg

4
  • Hemodynamically stable throughout the procedure
  • She remains apneic, is sweating, blushing and
    hypertensive after reversal of the
    nondepolarizing muscle relaxant

5
Discussion
  • Postoperative apnea
  • Sweating
  • Blushing
  • Hypertensive

6
  • Postoperative apnea
  • Residual anesthetic agent
  • I. Propofol
  • II. Sevoflurane
  • III. Fentanyl
  • Residual muscle relaxant
  • I. Suxamethonium(Succinylcholine)
  • II. Cisatracurium

7
  • Intraoperative hyperventilation
  • Electrolyte acid-base imbalance
  • Underline disease (ex stroke, liver disease)

8
Residual anesthetic agent
  • Propofol
  • bradycardia
  • Myoclonus
  • Apnea
  • Hypotension (especially with narcotics less with
    infusion)
  • Phlebitis (rare)
  • Reported to cause tissue necrosis on subcutaneous
    extravasations in small children

9
  • Sevoflurane
  • mild negative inotrope
  • little or no tarchycardia
  • may prolong the QT interval
  • depresses respiration
  • bronchodilator
  • slightly increases ICP

10
  • Fentanyl
  • Abdominal pain, dry mouth, diarrhea,
    constipation, indigestion, nausea
  • anxiety, confusion, depression,dizziness,
    fatigue, hallucinations, headache, insomnia,
    sleepiness,
  • impaired or interrupted breathing, shortness of
    breath
  • itching, sweating
  • urinary retention

11
Residual muscle relaxant
  • Suxamethonium (Succinylcholine)
  • Depolarizing muscle relaxant
  • Stimulates all cholinergic autonomic receptors
  • Cardiac dysrrhythmia
  • Hyperkalemia
  • Myalgia
  • Malignant hyperthermia
  • Increase intragastric pressure, intraocular
    pressure, and intracranial pressure
  • esp. low pseudocholinesterase activity,
    atypical pseudocholinesterase activity

12
low pseudocholinesterase activity
  • liver disease, advanced age, malnutrition,
    pregnancy, burns, oral contraceptives, monoamine
    oxidase inhibitors, echothiophate, cytotoxic
    drugs, neoplastic disease, anticholinesterase
    drugs(neostigmine) , tetrahydroaminacrine,
    hexafluorenium, and metoclopramide.

13
atypical pseudocholinesterase activity
  • Succinylcholine-induced neuromuscular blockade
    can be significantly prolonged if the patient has
    an abnormal genetic variant pseudocholinesterase
  • Dibucaine number Assess the presence of
    homozygous or heterozygous atypical
    cholinesterase variant, in patients who have low
    result of serum or plasma cholinesterase assay,
    and may be at risk of apnea when given
    succinylcholine muscle relaxant

14
  • Cisatracurium
  • Non-depolarizing muscle relaxant, competitive
  • Hofmann elimination
  • Unlike atracurium, dose not cause histamine
    release
  • Bradycardia, hypotension, flushing, Bronchospasm,
    Rash

15
  • Laudanosine
  • Metabolite of Cisatracurium
  • No neuromuscular blocking activity
  • Contribution to seizures in ICU patients remained
    undetermined

16
  • Sweating
  • sympathetic nerve stimulate
  • increased secretion
  • increased Ach
  • I. cocaine and amphetamine
  • II. Organophosphates
  • III. physostigmine, pyridostigmine, neostigmine,
    and edrophonium.

17
  • Blushing
  • sympathetic nerve stimulate
  • histamine release
  • I. Atropine and atropine-like agents
  • II. Neuromuscular blocker
  • Hypertensive
  • ? sympathetic nerve stimulate

18
management
  • Residual anesthetic agent
  • ?Discontinue anesthetic
  • ?naloxone
  • Residual muscle relaxant
  • ?prolonged paralysis from succinylcholine
  • caused by abnormal pseudocholinesterase
    should be treated with continued mechanical
    ventilation until muscle function returns to
    normal
  • ?anticholinesterases drug( ex neostigmine,
    edrophonium, and pyridostigmine)

19
  • Intraoperative hyperventilation
  • ? ABGhypocarbia
  • ? adjust ventilation,
  • ? postoprative hypoventilation
  • Electrolyte , acid-base imbalance
Write a Comment
User Comments (0)
About PowerShow.com